36 Medidata Solutions Testimonials

"Using MS Word documents for visit reporting wasted our CRAs’ time and the reviewer’s time. With Medidata’s cloud-based CTMS, which structures visit report data, CRAs spend 40 percent less time completing a report and site correspondences. We’ve also noticed a reduction in review-to-approval cycle times from 16 days to seven days."

“The partnership with Medidata further underscores TissueTech’s commitment to evidence-based medicine, scientific integrity and continuous research and innovation. Medidata’s unified platform provides us with the technology foundation to scale our clinical research, address the complexity of today’s clinical trials, and build and maintain efficiencies as we continue to grow.”

“Medidata’s choice to implement the Rave eCOA/ ePRO solution in a unified environment with Rave EDC allows the user to extend their study design knowledge and ease the ePRO design, especially for beginners.“

“Medidata AI literally rolled up their sleeves, helped us analyze the data, and suggested ways to improve our clinical trial design. They were essentially part of our statistical group. We worked with Medidata and leveraged that information when we went to the FDA.”

"Adopting Medidata's machine-learning capabilities for centralized monitoring will not only put us in line with the updated ICH E6 R2 guidelines, but will also allow us to view clinical information at a more holistic level, better prioritize trial resources, and maintain data quality and integrity."

"Major corporations such as pharmaceutical and medical device manufacturers and institutions such as hospitals and nursing facilities have also committed fraud, sometimes on a grand scale. OIG has a strong record of investigating these corporate and institutional frauds, which often involve complex billing frauds, kickbacks, accounting schemes, illegal marketing and physician self-referral arrangements."

"We didn’t go shopping, we knew we wanted to use Medidata and it was a matter of working to find the right study build model to fit our business needs.”

“A shared culture is the key to any successful partnership – Medidata’s commitment to integrity and to putting the client at the center of its work aligns perfectly with palleos’ values.”

“We have a strong partnership that goes way beyond a service provider relationship and enables us to drive high-quality analysis that would otherwise not be possible.”

“It is to everyone’s advantage to [use Medidata’s] unified platform so that there is one login. There is one way that people are accessing all the things they need to do with their data. If we’re thinking of patients and sites first, we have to think about that value…[so] they’re not worried about having multiple laptops and multiple logins.”

“Our partnership with Medidata has enabled us to offer top-notch service to sponsors. In the last decade, we’ve embraced the latest Rave EDC technology, including eCOA/ePRO via the Patient Cloud and Rave Coder. We’ve successfully configured intricate study designs, from early-phase oncology with numerous protocol changes to rare disease studies with diverse data collection methods.”

"We needed to find a trusted partner to work with us, to grow with us AND deliver and provide innovative technology solutions for our clinical trials, we found that partner in Medidata."

"Our partnership with Medidata has been very collaborative from a data management perspective in rolling out all the new applications and tools and integrating them with EDC. It’s made data management easier for reviewing the data, drawing out metrics, and building the forms. It’s an easier platform to design and then work with integrating new tools like RTSM or eCOA/ePRO.”

“What Medidata brings to the table, in addition to deep subject matter expertise, is the willingness to keep working until it is right. We can’t do that’ was never a phrase we heard from their Professional Services team.”

“The Professional Services group is an absolutely incredible resource. They taught me everything I needed to know so I could do it myself—quickly, easily and correctly… the first time.”